INTS Financials

Intensity Therapeutics Inc - Financial statements & key metrics

Stock Price

$5.36

Market Cap

$13.87M

0

EPS

$-8.56

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

-

Gross Profit

-

Operating Income

-

Net Income

$-16.27M

EPS (Diluted)

$-1.17

Balance Sheet Highlights

Total Assets

$4.78M

Total Liabilities

$1.86M

Shareholders Equity

-

Cash & Equivalents

$428,000

Total Debt

-

Cash Flow Highlights

Operating Cash Flow

$-15.22M

CapEx

-

Free Cash Flow

-

Profitability Metrics

ROE

-1.6%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is INTS revenue?

View INTS's income statement for detailed revenue data.

Is INTS profitable?

INTS reported a loss of $16.27M in the most recent quarter.

What is INTS market cap?

INTS has a market capitalization of $13.87M, making it a small-cap stock.

Does INTS have debt?

View INTS's balance sheet for debt information.

What is INTS cash flow?

Cash flow data is available in the full financial statements.

Explore Categories